Psychedelics in NHS services: exploring a model for real-world implementation of psilocybin
The British Journal of Psychiatry March 30, 2026 Katharine A. Smith, Edward Harcourt, Andrea Cipriani 1 citation
Psychedelics are increasingly described as a new therapeutic approach in a variety of mental disorders including depression. Oral psychedelics such as psilocybin have an acute effect evolving over 6-8 h and are generally given in combination with psychological support. There is debate on the exact role of this support and how and by whom it should be delivered. This has significant implications...